3/27/2024 | 30049049 | IRINOTECAN KABI INJ.500MG/25ML VIAL B.NO.87240075AA,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 5232 | NOS | 64917.92 | GERMANY | CHAWAPAYAL ICD |
3/27/2024 | 30049049 | IRINOTECAN KABI INJ.500MG/25ML VIAL B.NO.87240075AC,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 3260 | NOS | 40345.34 | GERMANY | CHAWAPAYAL ICD |
3/27/2024 | 30049049 | IRINOTECAN KABI INJ.500MG/25ML VIAL B.NO.87240075AH,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 300 | NOS | 3744.76 | GERMANY | CHAWAPAYAL ICD |
3/27/2024 | 30049049 | IRINOTECAN FRESENIUS KABI INJ.500MG/25MLVIAL B.NO.87240075AB,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 3260 | NOS | 40553.85 | GERMANY | CHAWAPAYAL ICD |
3/27/2024 | 30049049 | IRINOTECAN KABI INJ.500MG/25ML VIAL B.NO.87240075AE,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 2050 | NOS | 25479.82 | GERMANY | CHAWAPAYAL ICD |
3/27/2024 | 30049049 | IRINOTECAN KABI INJ.500MG/25ML VIAL B.NO.87240075AG,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 1046 | NOS | 13012.07 | GERMANY | CHAWAPAYAL ICD |
3/27/2024 | 30049049 | IRINOTECAN FRESENIUS KABI INJ.500MG/25MLVIAL B.NO.87240075AD,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 2350 | NOS | 29208.58 | GERMANY | CHAWAPAYAL ICD |
3/27/2024 | 30049049 | IRINOTECAN FRESENIUS KABI INJ.500MG/25MLVIAL B.NO.87240075AF,MFG.DT.02/2024, EXP.DT.01/2026 | FRESENIUS KABI ONCOLOGY LIMITED | 1048 | NOS | 13003.44 | GERMANY | CHAWAPAYAL ICD |
3/9/2024 | 30049049 | IRINOTECAN 20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION IRINOTECAN VENUS 20 MG/ML (100MG/5ML) | VENUS REMEDIES LIMITED | 200 | NOS | 949.17 | GERMANY | DELHI AIR |
2/20/2024 | 29349990 | IRINOTECAN HYDROCHLORIDE TRIHYDRATEKGS | LAURUS LABS LIMITED | 5.865 | KGS | 116184.31 | GERMANY | ACC SHAMSHABAD AIRPO |